Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
종목 코드 SNOA
회사 이름Sonoma Pharmaceuticals Inc
상장일Jan 26, 2007
CEOTrombly (Amy)
직원 수168
유형Ordinary Share
회계 연도 종료Jan 26
주소5445 Conestoga Court, Suite 150
도시BOULDER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호80301
전화18007599305
웹사이트https://sonomapharma.com/
종목 코드 SNOA
상장일Jan 26, 2007
CEOTrombly (Amy)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음